Published in Eur Arch Psychiatry Clin Neurosci on August 04, 2006
Insight in schizophrenia: associations with empathy. Eur Arch Psychiatry Clin Neurosci (2012) 1.55
Failures of metacognition and lack of insight in neuropsychiatric disorders. Philos Trans R Soc Lond B Biol Sci (2012) 1.28
Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull (2010) 0.92
Rumination and perceived impairment associated with depressive symptoms in a verbal adolescent-adult ASD sample. Autism Res (2014) 0.90
Schizophrenia with preserved insight is associated with increased perfusion of the precuneus. J Psychiatry Neurosci (2012) 0.86
Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia. BMC Psychiatry (2013) 0.84
Denial and acceptance coping styles and medication adherence in schizophrenia. J Nerv Ment Dis (2009) 0.83
Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit features. Schizophr Res (2011) 0.78
Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone. Patient Prefer Adherence (2015) 0.75
Insight in schizophrenia: relationship to positive, negative and neurocognitive dimensions. Indian J Psychol Med (2015) 0.75
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Illusion and well-being: a social psychological perspective on mental health. Psychol Bull (1988) 8.08
Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci (1982) 5.67
Insight and psychosis. Br J Psychiatry (1990) 4.64
The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl (1989) 4.53
Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia (1990) 3.79
The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry (1990) 3.75
Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med (1992) 3.00
Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry (1994) 2.69
Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain (1992) 2.64
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain (1988) 2.32
Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry (2000) 2.24
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry (1999) 1.77
Insight in schizophrenia: a meta-analysis. Schizophr Res (2003) 1.67
Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain (1997) 1.61
Awareness of illness in schizophrenia. Schizophr Bull (1991) 1.61
West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry (2000) 1.39
Executive function in first-episode schizophrenia. Psychol Med (1998) 1.39
Syndromes of chronic schizophrenia. Br J Psychiatry (1990) 1.35
A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med (1998) 1.34
The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med (2004) 1.26
Postpsychotic depression in schizophrenia. Arch Gen Psychiatry (1976) 1.25
The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr Res (2004) 1.21
Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res (2001) 1.18
Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry (2001) 1.16
Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl (2002) 1.14
Correlates of insight in first episode psychosis. Schizophr Res (2004) 1.06
Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res (2003) 1.05
Lack of insight in schizophrenia. Schizophr Bull (1994) 1.02
Insight in schizophrenia and mood disorders and its relation to psychopathology. Acta Psychiatr Scand (1994) 1.01
Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry (1996) 0.99
Unawareness of illness and its relationship with depression and self-deception in schizophrenia. Eur Psychiatry (1999) 0.99
Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. J Neuropsychiatry Clin Neurosci (2001) 0.99
Lack of insight among outpatients with schizophrenia. Psychiatr Serv (1997) 0.98
Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand (2003) 0.98
Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res (2000) 0.96
Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med (2003) 0.95
Correlates of insight and insight change in schizophrenia. Schizophr Res (1999) 0.95
Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull (2000) 0.95
Insight, neurocognitive function and symptom clusters in chronic schizophrenia. Schizophr Res (1997) 0.92
Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis (1998) 0.91
The relationship between insight, illness and treatment outcome in schizophrenia. Psychiatr Q (1998) 0.91
Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res (2000) 0.90
Correlates of insight in serious mental illness. J Nerv Ment Dis (2001) 0.90
Insight and neurocognition in schizophrenia. Schizophr Res (2003) 0.90
"To see oursels as others see us". Aubrey Lewis's insight. Br J Psychiatry (1999) 0.87
Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function. Acta Psychiatr Scand (1998) 0.87
Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test. J Nerv Ment Dis (1994) 0.87
Suicidal behavior in schizophrenia and its relationship to awareness of illness. Am J Psychiatry (1996) 0.87
Lack of insight in psychotic and affective disorders: a review of empirical studies. Harv Rev Psychiatry (1998) 0.86
Insight in paranoid schizophrenia--its relationship to psychopathology and premorbid adjustment. Compr Psychiatry (1998) 0.86
Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry (1999) 0.85
The relationship between symptoms and insight in schizophrenia: a longitudinal perspective. Schizophr Res (1998) 0.84
Insight in early psychosis: a 1-year follow-up. Schizophr Res (2004) 0.84
Reduced awareness of illness in first-episode psychosis. Compr Psychiatry (2001) 0.83
Insight and symptom change in schizophrenia and other disorders. Schizophr Res (2000) 0.83
Insight in first-admission psychotic patients. Schizophr Res (1996) 0.81
Insight and cognitive deficits in schizophrenia: evidence for a curvilinear relationship. Psychol Med (1996) 0.81
Insight and suicidality in schizophrenia: a replication study. J Nerv Ment Dis (2000) 0.80
Common sense, insight, and neuropsychological test performance in schizophrenia patients. Schizophr Bull (1996) 0.80
Insight in schizophrenia: its relationship to measures of executive functions. J Nerv Ment Dis (1999) 0.79
Lack of insight: its status within schizophrenic psychopathology. Biol Psychiatry (1994) 0.79
[Relationships between insight and medication adherence in subjects with psychosis]. Encephale (2003) 0.79
Weight gain during long-term treatment with olanzapine: a case series. Int Clin Psychopharmacol (2004) 0.78
Depression and the experience of psychological deficits in schizophrenia. Acta Psychiatr Scand (1993) 0.77
Insight and schizophrenia. Compr Psychiatry (2001) 0.77
Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res (2004) 0.76
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry (2003) 3.18
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. J Clin Psychiatry (2015) 2.67
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry (2011) 2.21
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ (2012) 2.17
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Visual exploration in Parkinson's disease and Parkinson's disease dementia. Brain (2013) 1.52
Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry (2006) 1.45
Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology (2010) 1.42
Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry (2009) 1.41
Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage (2006) 1.20
White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage (2007) 1.18
Age differences in emotion recognition skills and the visual scanning of emotion faces. J Gerontol B Psychol Sci Soc Sci (2007) 1.17
Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev (2010) 1.16
Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry (2005) 1.11
Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch Gen Psychiatry (2003) 1.10
A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res (2007) 1.08
Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. Br J Psychiatry (2008) 1.05
Role of the prescribing observatory for mental health. Br J Psychiatry (2012) 1.05
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis. Schizophr Bull (2012) 1.01
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br J Psychiatry (2008) 1.01
The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia. Biol Psychiatry (2004) 1.00
How to compare doses of different antipsychotics: a systematic review of methods. Schizophr Res (2013) 0.99
IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr Res (2008) 0.99
The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull (2011) 0.97
A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res (2012) 0.96
The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr Bull (2008) 0.96
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J Psychopharmacol (2009) 0.95
No psychiatry without psychopharmacology. Br J Psychiatry (2011) 0.95
Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol (2007) 0.93
Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biol Psychiatry (2010) 0.92
Adaptive and aberrant reward prediction signals in the human brain. Neuroimage (2009) 0.91
Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. Neuroimage (2009) 0.90
IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study. Schizophr Bull (2009) 0.90
Medicines Reconciliation on Admission to Inpatient Psychiatric Care: Findings from a UK Quality Improvement Programme. Ther Adv Psychopharmacol (2011) 0.89
Lithium in bipolar and other affective disorders: prescribing practice in the UK. J Psychopharmacol (2010) 0.87
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res (2011) 0.87
Schizophrenia--time to commit to policy change. Schizophr Bull (2014) 0.86
Gaze strategies during planning in first-episode psychosis. J Abnorm Psychol (2007) 0.86
A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine. Value Health (2007) 0.85
Nocturnal enuresis with antipsychotic medication. Br J Psychiatry (2012) 0.85
Non-verbal behaviour of patients with schizophrenia in medical consultations--a comparison with depressed patients and association with symptom levels. Psychopathology (2010) 0.84
The determinants and effect of shared care on patient outcomes and psychiatric admissions - an inner city primary care cohort study. Soc Psychiatry Psychiatr Epidemiol (2004) 0.84
Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling. BMC Psychiatry (2007) 0.84
A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr Res (2006) 0.84
Cognitive function in schizophrenia: insights from intelligence research. Br J Psychiatry (2013) 0.83
The role of the right inferior frontal gyrus in the pathogenesis of post-stroke psychosis. J Neurol (2014) 0.82
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophr Res (2013) 0.82
The effects of task instructions on pro and antisaccade performance. Exp Brain Res (2009) 0.81
Structural neural networks subserving oculomotor function in first-episode schizophrenia. Biol Psychiatry (2004) 0.81
Keeping an eye on the truth? Pupil size changes associated with recognition memory. Memory (2011) 0.79
Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. J Psychopharmacol (2007) 0.79
Contingency knowledge is necessary for learned motivated behaviour in humans: relevance for addictive behaviour. Addiction (2006) 0.79
Monitoring lithium therapy: the impact of a quality improvement programme in the UK. Bipolar Disord (2013) 0.79
Biofeedback treatment for Tourette syndrome: a preliminary randomized controlled trial. Cogn Behav Neurol (2014) 0.79
Is persistent ketamine use a valid model of the cognitive and oculomotor deficits in schizophrenia? Biol Psychiatry (2008) 0.78
Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used. Br J Psychiatry (2010) 0.78
Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1). Schizophr Res (2013) 0.77
Drug expectancy is necessary for stimulus control of human attention, instrumental drug-seeking behaviour and subjective pleasure. Psychopharmacology (Berl) (2006) 0.77
The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of Sexual Side-Effect Measurement. Ther Adv Psychopharmacol (2011) 0.76
Prescribing and monitoring lithium therapy: summary of a safety report from the National Patient Safety Agency. BMJ (2010) 0.75
The role of the temporal lobe in contextual sentence integration: A single-pulse transcranial magnetic stimulation study. Cogn Neurosci (2011) 0.75
Attitudes to atypical and conventional antipsychotic drug treatment in clinicians participating in the cutlass study. Int J Psychiatry Clin Pract (2005) 0.75